Ratio-Nystatin · DIN 02194228 · 100000U/g · Oint
General benefit; Health Canada lists this DIN as Cancelled post market since 2021-07-30 — choose a marketed DIN from the same-category list.Discontinued July 30, 2021 · checked November 18, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2021-07-30 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2021-07-30 — choose a marketed DIN from the same-category list.
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Ratio-Nystatin · DIN 02194228
Manufacturer: Ratiopharm Inc.; listing date 1997-10-31
Health Canada: Cancelled post market since 2021-07-30 · brand RATIO-NYSTATIN · ATC D01AA01 NYSTATIN · form Ointment · route Topical · ingredients NYSTATIN 100000 UNIT/G · company Teva canada limited · schedule Non-prescription drugs
Ratio-Nystatin: Formulary list price $0.13 per unit (the source does not state the unit; exact figure $0.1277). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02194228)
Source record
DIN 02194228: Ratio-Nystatin
Raw flags: sec3=Y
Item: 840408005; group id 823; item number 2006; lccId None; manufacturer id RPH
Source form: Oint; strength: 100000U/g
Recorded listing: General benefit
Source prices (unrounded): $0.1277; ministry $0.1277
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02194228
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=35799
Therapeutic Notes (formulary)
Nystatin is not effective in the treatment of Dermatophyte infections or Tinea versicolor.
Interchangeable products
Mycostatin · DIN 00029556 · not recorded
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Cancelled post market since July 30, 2021 — choose a marketed DIN from the same-category list.